Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at
http://www.sigma-aldrich.com.
About Sangamo Biosciences, Inc.: Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Sangamo also has a Phase 1 clinical trial to evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo also is develop
'/>"/>
SOURCE Sigma-Aldrich Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients2.
Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M. Finzi Memorial Student Summer Fellowships to Five Students3.
Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative4.
Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barretts Esophagus5.
Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis6.
Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)7.
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia8.
Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference9.
Researchers Discover Metabolite Linked to Aggressive Prostate Cancer10.
Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol11.
Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF